Baldness, acne and testicular germ cell tumours

International Journal of Andrology

Volumn 34, Issue 4 PART 2, 2011, Pages

  Trabert, B ^a   Sigurdson, A J ^a   Sweeney, A M ^b   Amato, R J ^c   Strom, S S ^d   Mcglynn, K A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Acne; Baldness; Case control; Hospital based; Testicular germ cell tumours

Indexed keywords

ANDROGEN;

ACNE; ADOLESCENT; ADULT; ADULTHOOD; ALOPECIA; ANDROGEN SYNTHESIS; ARTICLE; BODY SIZE; CANCER RISK; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; GERM CELL TUMOR; HAIR LOSS; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PUBERTY; RACE; RESIDENTIAL AREA;

ACNE VULGARIS; ADOLESCENT; ADULT; AGE OF ONSET; ALOPECIA; ANDROGENS; CASE-CONTROL STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; RISK FACTORS; TESTICULAR NEOPLASMS; TESTIS;

EID: 79960886801     PISSN: 01056263     EISSN: 13652605     Source Type: Journal    
DOI: 10.1111/j.1365-2605.2010.01125.x     Document Type: Article

References (26)

1. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou P, Waldron W et al. (2010) SEER Cancer Statistics Review, 1975-2007. National Cancer Institute, Bethesda, MD.
2. Balducci R, Ghirri P, Brown TR, Bradford S, Boldrini A, Boscherini B, Sciarra F & Toscano V. (1996) A clinician looks at androgen resistance. Steroids 61, 205-211.
3. Bonne C, Saurat JH, Chivot M, Lehuchet D & Raynaud JP. (1977) Androgen receptor in human skin. Br J Dermatol 97, 501-503.
4. Goriely A, Hansen RM, Taylor IB, Olesen IA, Jacobsen GK, McGowan SJ, Pfeifer SP, McVean GA, Rajpert-De Meyts E & Wilkie AO. (2009) Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors. Nat Genet 41, 1247-1252.
5. Depue RH, Pike MC & Henderson BE. (1983) Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst 71, 1151-1155.
6. Forman D, Pike MC, Davey G, Dawson S, Baker K, Chilvers CED, Oliver RTD & Coupland CAC. (1994) Aetiology of testicular cancer: association with congenital abnormalities, age at puberty, infertility, and exercise. BMJ 308, 1393-1399.
7. Hamilton J. (1942) Male hormone stimulation is prerequisite and an incitant in common baldness. Am J Anat 71, 451-480.
8. Hamilton J. (1951) Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci 53, 708-728.
9. Hay JB & Hodgins MB. (1974) Metabolism of androgens by human skin in acne. Br J Dermatol 91, 123-133.
10. Imperato-McGinley J & Zhu YS. (2002) Androgens and male physiology the syndrome of 5alpha-reductase-2 deficiency. Mol Cell Endocrinol 198, 51-59.
11. Jagou M, Bastuji-Garin S, Bourdon-Lanoy E, Penso-Assathiany D & Roujeau JC. (2006) Poor agreement between self-reported and dermatologists' diagnoses for five common dermatoses. Br J Dermatol 155, 1006-1012.
12. Littman AJ & White E. (2005) Reliability and validity of self-reported male balding patterns for use in epidemiologic studies. Ann Epidemiol 15, 771-772.
13. McGlynn KA & Cook MB. (2009) Etiologic factors in testicular germ-cell tumors. Future Oncol 5, 1389-1402.
14. Norwood OT. (1975) Male pattern baldness: classification and incidence. South Med J 68, 1359-1365.
15. Petridou E, Roukas KI, Dessypris N, Aravantinos G, Bafaloukos D, Efraimidis A, Papacharalambous A, Pektasidis D, Rigatos G & Trichopoulos D. (1997) Baldness and other correlates of sex hormones in relation to testicular cancer. Int J Cancer 71, 982-985.
16. Rajpert-De Meyts E & Skakkebaek NE. (1993) The possible role of sex hormones in the development of testicular cancer. Eur Urol 23, 54-59.
17. Richiardi L, Pettersson A & Akre O. (2007) Genetic and environmental risk factors for testicular cancer. Int J Androl 30, 230-240.
18. Sansone G & Reisner RM. (1971) Differential rates of conversion of testosterone to dihydrotestosterone in acne and in normal human skin - a possible pathogenic factor in acne. J Invest Dermatol 56, 366-372.
19. Sawaya ME. (1999) Androgenetic alopecia: overview. J Cutan Med Surg 3(Suppl 3), S14-S20.
20. Sawaya ME & Price VH. (1997) Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol 109, 296-300.
21. Sigurdson AJ, Chang S, Annegers JF, Duphorne CM, Pillow PC, Amato RJ, Hutchinson LP, Sweeney AM & Strom SS. (1999) A case-control study of diet and testicular carcinoma. Nutr Cancer 34, 20-26.
22. Skakkebaek NE, Rajpert-De Meyts E, Jorgensen N, Carlsen E, Petersen PM, Giwercman A, Andersen AG, Jensen TK, Andersson AM & Muller J. (1998) Germ cell cancer and disorders of spermatogenesis: an environmental connection? APMIS 106, 3-11.
23. Sonke GS, Chang S, Strom SS, Sweeney AM, Annegers JF & Sigurdson AJ. (2007) Prenatal and perinatal risk factors and testicular cancer: a hospital-based case-control study. Oncol Res 16, 383-387.
24. Strauss JS, Kligman AM & Pochi PE. (1962) The effect of androgens and estrogens on human sebaceous glands. J Invest Dermatol 39, 139-155.
25. Taylor R, Matassa J, Leavy JE & Fritschi L. (2004) Validity of self reported male balding patterns in epidemiological studies. BMC Public Health 4, 60.
26. Walcott FL, Hauptmann M, Duphorne CM, Pillow PC, Strom SS & Sigurdson AJ. (2002) A case-control study of dietary phytoestrogens and testicular cancer risk. Nutr Cancer 44, 44-51.